Τετάρτη 24 Οκτωβρίου 2018

A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

Condition:   Asthma Interventions:   Drug: GSK2245035;   Drug: Placebo;   Drug: FP-DPI;   Drug: Albuterol/Salbutamol;   Other: eDairy;   Other: ACQ-6 Sponsor:   GlaxoSmithKline Withdrawn (Source: ClinicalTrials.gov)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2RcNPPu

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.